ENOUGH

ENOUGH is a biotechnology startup with a mission to "make protein sustainable." Utilizing fermentation as a means to meet the future food protein demands, ENOUGH produces ABUNDA® mycoprotein, a versatile and complete food ingredient rich in essential amino acids and dietary fiber. This innovative protein source can be adapted into alternative/vegan meat, seafood, and dairy products, catering to the needs of a rapidly growing market. The company's strategy involves supplying ABUNDA as a B2B food ingredient to consumer brands and retailers, aiming to address the escalating demand for healthy and sustainable protein on a large scale.

The potential impact of introducing 1 million tonnes of ABUNDA mycoprotein by 2032 is significant, akin to replacing 5 million cows, over a billion chickens, and reducing more than 5 million tonnes of CO2 emissions. Founded in 2015 and headquartered in the United Kingdom, ENOUGH has garnered the attention of investors, securing a €280.00K pre-seed investment on 27 August 2024 from PurposeTech VC, Klara Losert, and EQT Scout.